[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100649747":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":23,"locations":29,"responsibleParty":44,"collaborators":18,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":18,"eligibilityCriteria":51,"healthyVolunteers":48,"sex":52,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":18,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":18,"overallStatus":66,"whyStopped":18,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Kutahya Health Sciences University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"posterior tibial nerve stimulation, PTNS","EXPERIMENTAL","50 patient who assessed after 12 weeks of treatment",[13],"Device: posterior tibial nerve stimulation, PTNS",{"label":15,"type":16,"description":17,"interventionNames":18},"standart treatment","NO_INTERVENTION","standart treatment group, wil folllow 12 months",null,[20],{"type":21,"name":9,"description":9,"armGroupLabels":22,"otherNames":18},"DEVICE",[9],[24],{"name":25,"role":26,"phone":27,"phoneExt":18,"email":28},"Halil i ivelik, Assistant Professor, MD","CONTACT","+905423618713","halib_ive@hotmail.com",[30],{"facility":5,"status":18,"city":31,"state":31,"zip":32,"country":33,"countryCode":18,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Kütahya","43000","Turkey (Türkiye)",{"type":35,"coordinates":36},"Point",[37,38],29.98333,39.42417,{"lat":38,"lon":37},[41],{"name":42,"role":26,"phone":43,"phoneExt":18,"email":28},"KSBU Evliya Celebi Research Hospital KSBU Evliya Celebi Research Hospital, Hospital Chief","+902743000081",{"type":45,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100649747","efficacy-of-transcutaneous-electrical-stimulation-therapy-in-the-treatment-of-overactive-bladder-developing-after-stroke-100649747",false,"NCT07740668","Efficacy of Transcutaneous Electrical Stimulation Therapy in the Treatment of Overactive Bladder Developing After Stroke","Inclusion Criteria:\n\n* Female\n* Age 40 to 70 years\n* History of ischemic or hemorrhagic stroke at least 6 months before enrollment\n* Presence of overactive bladder symptoms\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* Age outside the study range\n* Pregnancy or breastfeeding\n* Active urinary tract infection\n* Neurogenic conditions other than stroke affecting bladder function\n* Inability to comply with study procedures\n* Refusal or inability to provide informed consent","FEMALE","40 Years","70 Years",{"count":56,"type":57},50,"ESTIMATED","INTERVENTIONAL",[60],"NA","This study is a prospective, randomized controlled clinical trial designed to evaluate the efficacy of transcutaneous electrical stimulation (posterior tibial nerve stimulation, PTNS) in the treatment of overactive bladder (OAB) developing after stroke.\n\nPrimary Hypothesis: PTNS therapy will significantly improve OAB symptoms in post-stroke patients compared to standard care\u002Fsham stimulation.\n\nPrimary Outcome Measure: Change from baseline in Overactive Bladder Symptom Score (OABSS) and\u002For frequency of urgency episodes as assessed after 12 weeks of treatment.\"",[63,64,65],"Stroke","Overactive Bladder (OAB)","Tibial Nerve","NOT_YET_RECRUITING","2026-07-28",{"date":69,"type":70},"2026-07-31","ACTUAL",{"date":72,"type":57},"2026-09-01",{"date":74,"type":57},"2027-10-01",{"name":5,"class":6},1]